Journal articleCancer Cell2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.
- Journal
- Cancer Cell
- Published
- 18 June 2020
- Citations
- 147
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer K08CA218420↗
- Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer K99CA226342↗
- Project 2: Splicing Dysregulation in Cancer P01CA013106↗
- MOLECULAR THERAPEUTICS RESEARCH PROGRAM P30CA023108↗
- Altered mRNA splicing dependent on mutant p53 identifies novel therapeutic vulnerability in pancreatic cancer R00CA226342↗
- Comprehensive genetic dissection of druggable KRAS targets R01CA204228↗
- Targeting undruggable RAS for cancer treatment R35CA232113↗